Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colecalciferol as Add-on to Interferon-beta-1b in MS
NCT01432704Phase 3Completed
- Sponsor
- University of Turku
- Start
- Mar 2008
- Primary completion
- May 2011
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial in multiple sclerosis (MS) comparing Colecalciferol with Placebo (2 arms). Primary endpoints: Safety and tolerability of add-on treatment with colecalciferol at 12 months and MRI T2 Burden of Disease at 12 months. Started Mar 2008; status: completed.
02
Drugs
cholecalciferol
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT01432704.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01432704.